Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
Abstract Tescalcin (TESC; also known as calcineurin B homologous protein 3, CHP3) has recently reported as a regulator of cancer progression. Here, we showed that the elevation of TESC in non-small cell lung cancer (NSCLC) intensifies epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC...
Guardado en:
Autores principales: | Jei Ha Lee, Soo Im Choi, Rae Kwon Kim, Eun Wie Cho, In Gyu Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ef08a7a1b0645949972a3ac06bfbd68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting therapy-resistant lung cancer stem cells via disruption of the AKT/TSPYL5/PTEN positive-feedback loop
por: In-Gyu Kim, et al.
Publicado: (2021) -
IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK
por: Christine E. Lehman, et al.
Publicado: (2021) -
REV1 Inhibition Enhances Radioresistance and Autophagy
por: Kanayo E. Ikeh, et al.
Publicado: (2021) -
Cortical thickness is differently associated with ALDH2 rs671 polymorphism according to level of amyloid deposition
por: Yong Hyuk Cho, et al.
Publicado: (2021) -
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
por: Aryan Stanley, et al.
Publicado: (2017)